Investigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trial
Open Access
- 16 April 2020
- Vol. 10 (4), e036650
- https://doi.org/10.1136/bmjopen-2019-036650
Abstract
Introduction Drug-related problems (DRPs) are a major cause of unplanned hospital admissions among elderly people, and transitions of care have been emphasised as a key area for improving patient safety. We have designed a complex clinical pharmacist intervention that targets people ≥75 years of age undergoing transitions of care from hospital to home and primary care. The main objective is to investigate if the intervention can reduce the risk of unplanned drug-related readmission within the first 180 days after the person is discharged from hospital. Methods and analysis This is a randomised, controlled, superiority trial with two parallel arms. A total of 700 people ≥75 years will be assigned to either intervention or routine care (control). The intervention, which aims to find and manage DRPs, is initiated within a week of the person being discharged from hospital and combines repeated medical chart reviews, phone interviews and in some cases medication reviews. People in both study arms may have been the subject of a medication review during their ward stay. As the primary outcome, we will measure time until unplanned drug-related readmission within 180 days of leaving hospital and use log rank tests and Cox proportional hazard models to analyse differences between the groups. Further investigations of subgroup effects and adjustments of the regression models will be based on heart failure and cognitive impairment as prognostic factors. Ethics and dissemination The study has been approved by the Regional Ethical Review Board in Umeå (registration numbers 2017-69-31M, 2018-83-32M and 2018-254-32M). We intend to publish the results with open access in international peer-reviewed journals and present our findings at international conferences. The trial is expected to result in more than one published article and form part of two PhD theses. Trial registration number NCT03671629Funding Information
- Vetenskapsrådet (2,400,000 SEK)
- Svenska Läkaresällskapet (200,000 SEK)
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2,930,000 SEK)
- Region Västerbotten (1,976,000 SEK)
- Umeå University Foundation for Medical Research (95,000 SEK)
This publication has 39 references indexed in Scilit:
- Medication Reviews by Clinical Pharmacists at Hospitals Lead to Improved Patient Outcomes: A Systematic ReviewBasic & Clinical Pharmacology & Toxicology, 2013
- Adverse Drug Events as a Cause of Hospitalization in Older AdultsDrug Safety, 2012
- Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisitsEuropean Journal of Clinical Pharmacology, 2011
- Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in GermanyJournal of Evaluation in Clinical Practice, 2010
- Medication Adherence in Healthy EldersJournal of Aging and Health, 2009
- Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005BMC Clinical Pharmacology, 2007
- Medical errors related to discontinuity of care from an inpatient to an outpatient settingJournal of General Internal Medicine, 2003
- Adverse drug reactions as a cause for admissions to a department of internal medicinePharmacoepidemiology and Drug Safety, 2002
- Prevalence of dementia disorders in institutionalized Swedish old people THE WORK LOAD IMPOSED BY CARING FOR THESE PATIENTSActa Psychiatrica Scandinavica, 1981